A thyroid nodule is an extremely common finding — up to 50% of adults have thyroid nodules detectable on ultrasound. The vast majority are entirely benign and require no treatment beyond observation. But a small proportion — approximately 5–10% — turn out to be malignant, and knowing which nodules require surgery and which can be safely monitored is one of the most common clinical decisions in endocrine surgery.
In this article I want to explain clearly how thyroid nodules are evaluated, what your FNAC (fine needle aspiration cytology) result means, and when surgery is recommended — and when it is not.
How Thyroid Nodules are Evaluated
The evaluation of a thyroid nodule follows a clear pathway. First, thyroid function tests (T3, T4, TSH) assess whether the nodule is affecting thyroid hormone production. Then, an ultrasound characterises the nodule — its size, composition, borders, calcifications, and blood flow — and stratifies risk. High-risk features on ultrasound prompt a fine needle aspiration biopsy (FNAC).
FNAC involves passing a thin needle into the nodule under ultrasound guidance and sampling cells for cytological analysis. It is a quick, essentially painless outpatient procedure that gives the single most important piece of information in deciding whether surgery is needed.
Understanding Your FNAC Result — The Bethesda Classification
FNAC results are reported using the Bethesda System for Reporting Thyroid Cytopathology — a standardised six-category classification that guides management.
| Bethesda Category | Description | Malignancy Risk | Recommendation |
|---|---|---|---|
| I | Non-diagnostic / Unsatisfactory | Indeterminate | Repeat FNAC |
| II | Benign | 0–3% | Surveillance ultrasound — no surgery |
| III | Atypia of Undetermined Significance (AUS) | ~15% | Repeat FNAC or molecular testing |
| IV | Follicular Neoplasm / Suspicious for FN | 25–40% | Surgery — hemithyroidectomy |
| V | Suspicious for Malignancy | 60–75% | Surgery — usually total thyroidectomy |
| VI | Malignant | >97% | Surgery — total thyroidectomy ± neck dissection |
A Bethesda II result is reassuring — benign nodules have a less than 3% malignancy risk and are managed with surveillance, not surgery. However, nodules that grow significantly or develop new suspicious features on follow-up ultrasound may need repeat FNAC regardless of the initial result.
When Surgery is Clearly Indicated
Bethesda V or VI — suspicious or confirmed malignancy on FNAC. Total thyroidectomy with or without central neck dissection is the standard treatment for most thyroid cancers.
Bethesda IV — follicular neoplasm. Because follicular carcinoma cannot be distinguished from a benign follicular adenoma on cytology alone (capsular invasion is the defining feature and can only be seen on the surgical specimen), hemithyroidectomy is performed. If the final pathology confirms carcinoma, a completion thyroidectomy is then performed.
Compressive symptoms — a benign goitre causing difficulty breathing, swallowing, or a sensation of pressure in the neck is an indication for surgery regardless of cytology.
Retrosternal goitre — a goitre extending behind the sternum may compromise the airway and requires surgical removal.
Hyperthyroidism not controlled by medication — surgery is one of the definitive treatments for Graves' disease and toxic nodular goitre.
Types of Thyroid Cancer and Their Outlook
Papillary thyroid carcinoma — the most common thyroid cancer (85%). Excellent prognosis — 10-year survival over 95% for most patients. Treated with total thyroidectomy ± radioactive iodine.
Follicular thyroid carcinoma — second most common (10%). Generally good prognosis but more likely to spread via the bloodstream than lymph nodes. Total thyroidectomy and radioactive iodine.
Medullary thyroid carcinoma — arises from C-cells, not follicular cells. Does not respond to radioactive iodine. Associated with MEN2 syndromes. Requires total thyroidectomy and central neck dissection. Genetic testing for RET mutations is important.
Anaplastic thyroid carcinoma — rare and aggressive. Requires urgent multidisciplinary assessment. Surgery, radiation, and systemic therapy are combined.
Will I Need Medication After Surgery?
After total thyroidectomy, daily thyroxine (levothyroxine) replacement is required for life — the thyroid gland has been removed and cannot produce its own hormone. This is a simple tablet taken once daily and most patients adapt well.
After hemithyroidectomy, approximately 70–80% of patients maintain sufficient thyroid function with the remaining lobe and do not need replacement therapy.
Voice and Parathyroid Concerns
The two most common concerns about thyroid surgery are voice change and calcium problems. Both are related to structures immediately adjacent to the thyroid gland.
The recurrent laryngeal nerve — which controls the vocal cords — runs directly behind the thyroid. At our centre, intraoperative nerve monitoring is used on every thyroid case. Permanent voice change occurs in less than 1% of operations in experienced hands.
The parathyroid glands — four tiny glands that regulate calcium — are located around the thyroid and can be inadvertently affected during surgery. Temporary low calcium (hypoparathyroidism) occurs in some patients and is managed with supplements. Permanent hypoparathyroidism is uncommon in high-volume centres.
Dr. Narayana Subramaniam
Intraoperative nerve monitoring on every thyroid case. <1% voice change rate. Consultation within 48 hours.
WhatsApp for ConsultationConcerned About a Thyroid Nodule or FNAC Result?
WhatsApp your ultrasound and FNAC reports — preliminary opinion within 4 hours.